The study, published in the journal Nature Microbiology, focused on a type of drug-resistant bacteria called Gram-negative bacteria, which are responsible for a wide range of infections, including pneumonia, urinary tract infections, and sepsis. These bacteria have an outer membrane that makes them resistant to many antibiotics, making them difficult to treat.
The researchers found that Gram-negative bacteria use a specialized protein secretion system called the type VI secretion system (T6SS) to secrete toxins. The T6SS is a complex molecular machine that spans the bacterial cell envelope and allows the bacteria to inject toxins directly into host cells.
Using cryo-electron microscopy, the researchers obtained a detailed look at the structure of the T6SS in action. They found that the T6SS forms a needle-like structure that extends from the bacterial cell surface and penetrates the host cell membrane. The tip of the needle is capped with a protein complex that forms a pore in the host cell membrane, allowing the toxins to be delivered into the host cell cytoplasm.
The researchers also identified several key proteins that are involved in the assembly and function of the T6SS. These proteins could potentially be targeted by new drugs to inhibit the secretion of toxins and reduce the virulence of drug-resistant bacteria.
"Understanding the structure and function of the T6SS provides a new framework for developing therapies to combat drug-resistant bacteria," said the senior author of the study. "Targeting the T6SS could potentially reduce the virulence of these bacteria and improve treatment outcomes for patients."
The study is a significant step forward in the fight against drug-resistant bacteria and opens up new avenues for the development of novel antibiotics and therapeutic strategies.
